Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd. saw its stock price drop significantly, contrasting with the broader market's performance. Over the past month, the company has faced notable declines, although it has shown resilience over the past year. Chugai maintains a strong long-term fundamental position with solid financial metrics.

Chugai Pharmaceutical Co., Ltd. saw its stock price decline significantly today, contrasting with the broader market. Despite recent fluctuations, the company maintains strong long-term fundamentals, including a high average Return on Equity and consistent growth in net sales and operating profit, alongside a low debt profile.

Chugai Pharmaceutical Co., Ltd. saw a significant stock decline today, contrasting with the rising Japan Nikkei 225. Despite recent short-term losses, the company maintains strong long-term fundamentals, including a solid Return on Equity and low debt levels, while trading at a premium valuation compared to peers.

Chugai Pharmaceutical Co., Ltd. has seen notable stock performance, gaining 5.26% on February 24, 2026, and achieving an intraday high of JPY 10,220.00. The company has shown impressive growth over various timeframes, supported by strong financial metrics, including a return on equity of 22.39% and significant annual sales growth.

Chugai Pharmaceutical Co., Ltd. saw a significant stock price decline today, contrasting with the broader market's performance. Despite this downturn, the company maintains strong long-term fundamentals, including a high Return on Equity and consistent growth in net sales and operating profit, alongside low debt levels and solid cash reserves.

Chugai Pharmaceutical Co., Ltd. saw its stock price decline significantly today, contrasting with the broader market's performance. Despite this drop, the company maintains strong fundamentals, including a high Return on Equity and consistent positive results over recent quarters, supported by low debt and healthy cash reserves.

Chugai Pharmaceutical Co., Ltd. saw a significant rise on October 7, 2025, outperforming the Japan Nikkei 225. The company boasts strong fundamentals, including a high Return on Equity and impressive growth in net sales and operating profit. Its financial health is supported by low debt and ample cash reserves.

Chugai Pharmaceutical Co., Ltd. has seen notable stock performance, gaining 6.03% on October 6, 2025, and achieving an intraday high of JPY 7,271.00. The company has demonstrated impressive growth over the past week and month, supported by strong financial metrics and consistent positive results in the pharmaceuticals sector.

Chugai Pharmaceutical Co., Ltd. saw a significant stock price decline today, contrasting with the broader market's performance. Despite recent challenges, including year-to-date and one-year declines, the company has shown strong long-term growth and solid financial metrics, maintaining a substantial market capitalization in the pharmaceuticals sector.